Naltrexone Related Clinical Trials
Naltrexone for Heavy Drinking in Young Adults [Completed]
The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease [Completed]
Low Dose Naltrexone for Glioma Patients [Completed]
Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse. [Completed]
Naltrexone and Hypoglycemia in Type 1 Diabetes [Completed]
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence [Completed]
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder [Terminated]
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care [Recruiting]
Improved Strategies for Outpatient Opioid Detoxification [Recruiting]
Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence [Recruiting]
Effects of Naltrexone on Nicotine Reinforcement [Completed]
Naltrexone for Individuals of East Asian Descent [Recruiting]
The Effects of Naltrexone on Active Crohn's Disease [Completed]
Dronabinol Naltrexone Treatment for Opioid Dependence [Completed]
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site [Active, not recruiting]
Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder [Completed]
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors [Recruiting]
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease [Withdrawn]
Control of Cognition [Recruiting]
Pilot Study of Depot NTX in Homeless Veterans [Terminated]
The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients [Not yet recruiting]
Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM [Recruiting]
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study. [Completed]
A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery [Active, not recruiting]
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment [Recruiting]
Naltrexone Treatment for Alcoholic Women [Completed]
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations [Recruiting]
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (Mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers [Completed]
Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence [Recruiting]
Managing Alcoholism in People Who Do Not Respond to Naltrexone [Completed]
Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers [Completed]
ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids [Completed]
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors [Recruiting]
Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects [Completed]
Low-Dose Naltrexone for Depression Relapse and Recurrence [Completed]
Memantine as a Supplement to Naltrexone in Treating Heroin Dependence [Completed]
Naltrexone Treatment of Alcohol Abuse in Schizophrenia [Completed]
ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults [Completed]
Targeted Naltrexone for Problem Drinkers [Completed]
Trial of Naltrexone and Dextromethorphan for Gulf War Illness [Recruiting]
ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) [Terminated]
Adherence to HIV Therapy in Heroin Addicts [Not yet recruiting]
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence [Completed]
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Withdrawn]
Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT [Completed]
Investigation of Naltrexone for Pathological Gambling [Active, not recruiting]
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence [Completed]
Naltrexone in Treating Women With Metastatic Breast Cancer That Did Not Respond to Hormone Therapy [Terminated]
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain [Completed]
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway [Recruiting]
Efficacy of Naltrexone in Women's Smoking Cessation [Completed]
Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services [Completed]
Understanding Treatment Response With Naltrexone Among White Alcoholics [Completed]
Naltrexone for Antipsychotic-Induced Weight Gain [Recruiting]
Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users [Not yet recruiting]
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain [Completed]
ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults [Completed]
Extended-release Naltrexone for Alcohol Dependence in Primary Care [Completed]
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 [Completed]
Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ [Completed]
Alcohol Use Disorder hOsPital Treatment Trial [Not yet recruiting]
Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone [Recruiting]
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence [Completed]
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) [Completed]
ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®) [Completed]
Biomarkers of Injectable Extended Release Naltrexone Treatment [Enrolling by invitation]
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry [Recruiting]
Naltrexone & SSRI in Alcoholics With Depression/PTSD [Active, not recruiting]
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. [Recruiting]
Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) [Recruiting]
Double-Blind Naltrexone in Compulsive Sexual Behavior [Completed]
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts [Completed]
Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial [Terminated]
Study of Naltrexone for Methamphetamine Addiction [Completed]
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects [Completed]
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer [Recruiting]
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer [Terminated]
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia [Recruiting]
The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse [Active, not recruiting]
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment [Recruiting]
Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. [Completed]
A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users [Completed]
N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence [Recruiting]
A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects [Completed]
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) [Completed]
ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals [Completed]
ALK21-014: Efficacy and Safety of Medisorb� Naltrexone (VIVITROL�) After Enforced Abstinence [Completed]
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Terminated]
Naltrexone for Impulse Control Disorders in Parkinson's Disease [Completed]
Cocaine Use Reduction With Buprenorphine [Completed]
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone [Completed]
Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone [Active, not recruiting]
Extended Release Naltrexone for Opioid-Dependent Youth [Recruiting]
Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland [Completed]
Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence [Completed]
Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone [Completed]
Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence [Completed]
Addiction Treatment in Russia: Oral vs. Naltrexone Implant [Completed]
Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction [Completed]
|
